Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
GeneDx Holdings Corp. stock logo
WGS
GeneDx
$38.94
-1.4%
$65.54
$32.21
$170.87
$1.17B2.061.77 million shs1.15 million shs
7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply click the link below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
GeneDx Holdings Corp. stock logo
WGS
GeneDx
-1.39%+12.19%-36.14%-57.05%-36.09%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
GeneDx Holdings Corp. stock logo
WGS
GeneDx
$38.94
-1.4%
$65.54
$32.21
$170.87
$1.17B2.061.77 million shs1.15 million shs
7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply click the link below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
GeneDx Holdings Corp. stock logo
WGS
GeneDx
-1.39%+12.19%-36.14%-57.05%-36.09%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
GeneDx Holdings Corp. stock logo
WGS
GeneDx
2.63
Moderate Buy$96.43147.63% Upside

Current Analyst Ratings Breakdown

Latest WGS Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/5/2026
GeneDx Holdings Corp. stock logo
WGS
GeneDx
Reiterated RatingBuy$85.00
5/5/2026
GeneDx Holdings Corp. stock logo
WGS
GeneDx
Set Price TargetBuy$100.00 ➝ $75.00
5/5/2026
GeneDx Holdings Corp. stock logo
WGS
GeneDx
Reiterated RatingOverweight$155.00 ➝ $75.00
5/5/2026
GeneDx Holdings Corp. stock logo
WGS
GeneDx
Lower Price TargetBuy$100.00 ➝ $70.00
5/5/2026
GeneDx Holdings Corp. stock logo
WGS
GeneDx
Lower Price TargetBuy$170.00 ➝ $90.00
4/24/2026
GeneDx Holdings Corp. stock logo
WGS
GeneDx
DowngradeStrong-BuyHold
4/20/2026
GeneDx Holdings Corp. stock logo
WGS
GeneDx
Set Price TargetBuy$170.00 ➝ $100.00
3/30/2026
GeneDx Holdings Corp. stock logo
WGS
GeneDx
Lower Price TargetBuy$170.00 ➝ $100.00
2/25/2026
GeneDx Holdings Corp. stock logo
WGS
GeneDx
UpgradeHoldStrong-Buy
2/24/2026
GeneDx Holdings Corp. stock logo
WGS
GeneDx
Reiterated RatingOverweight$160.00 ➝ $130.00
(Data available from 5/14/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
GeneDx Holdings Corp. stock logo
WGS
GeneDx
$427.54M2.70$2.26 per share17.23$8.56 per share4.55
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
GeneDx Holdings Corp. stock logo
WGS
GeneDx
-$21.02M-$2.68N/A44.76N/A-17.58%9.15%5.21%N/A

Latest WGS Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/4/2026Q1 2026
GeneDx Holdings Corp. stock logo
WGS
GeneDx
-$0.06-$0.28-$0.22-$2.16$112.46 million$102.25 million
2/23/2026Q4 2025
GeneDx Holdings Corp. stock logo
WGS
GeneDx
$0.11$0.14+$0.03-$0.61$120.80 million$120.99 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
GeneDx Holdings Corp. stock logo
WGS
GeneDx
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
GeneDx Holdings Corp. stock logo
WGS
GeneDx
0.38
3.09
2.95

Institutional Ownership

CompanyInstitutional Ownership
GeneDx Holdings Corp. stock logo
WGS
GeneDx
61.72%

Insider Ownership

CompanyInsider Ownership
GeneDx Holdings Corp. stock logo
WGS
GeneDx
29.60%
CompanyEmployeesShares OutstandingFree FloatOptionable
GeneDx Holdings Corp. stock logo
WGS
GeneDx
1,30029.69 million20.90 millionOptionable

Recent News About These Companies

GeneDx: The 50% Crash Creates A Compelling Entry
Why is GeneDx stock surging Thursday?

New MarketBeat Followers Over Time

Media Sentiment Over Time

GeneDx stock logo

GeneDx NASDAQ:WGS

$38.94 -0.55 (-1.39%)
Closing price 05/13/2026 04:00 PM Eastern
Extended Trading
$38.93 -0.01 (-0.03%)
As of 06:16 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

GeneDx Holdings Corp., through its subsidiaries, provides genomics-related diagnostic and information services. The company offers Centrellis, an AI-driven health intelligence platform that integrates digital tools and artificial intelligence allowing scientists to ingest and synthesize clinical and genomic data to deliver comprehensive health insights. It provides genetic diagnostic tests, screening solutions, and information with a focus on pediatrics, rare diseases for children and adults, and hereditary cancer screening. GeneDx Holdings Corp. was founded in 2017 and is headquartered in Stamford, Connecticut.